B8.042 Pathology of Prostate Flashcards

1
Q

systemic symptoms of acute bacterial prostatitis

A

fever, chills, malaise, urinary irritative and obstructive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

common causes of acute bacterial prostatitis

A

E. coli
other gram - rods
enterococci
staphylocci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

routes of infection of prostate

A
  1. direct implantation
  2. lymphohematogenous spreading
  3. surgical manipulation (indwelling catheter, TURP, etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

acute prostatitis on histo

A

neutrophils in lumen of glands, stroma, and epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

other types of prostatitis

A

chronic bacterial
abacterial
granulomatous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DRE findings in prostatitis

A

hot, boggy, tender prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diagnosis of acute bacterial prostatitis

A

positive urine culture

clinical features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

features of chronic bacterial prostatitis

A

similar to acute, but without fast onset
lacks fever and chills
can cause recurrent UTIs
positive urine culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

features of abacterial prostatitis

A

similar to chronic bacterial prostatitis, but with negative cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

types of granulomatous prostatitis

A

infectious: fungal or mycobacterial granulomatous prostatitis
non-infectious: nonspecific granulomatous prostatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most common cause of granulomatous prostatitis

A

BCG treatment effect

-treatment of bladder cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

chronic prostatitis on histo

A

lymphocytic infiltrate (instead of neutrophils like acute)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

granulomatous inflammation on histo

A

epithelioid histiocytes
multinucleated giant cells
focis of granuloma formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

histo in BPH

A

hyperplasia of prostatic stromal and epitheial cells, resulting in formation of large nodules
proliferative prostatic glands
nodules still only have 2 cell layers: basal and secretory THUS benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

symptoms of BPH

A

urethral obstruction
urine retention
increased incidence of urinary infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pathogeneis of BPH

A

conversion of T to DHT in stromal cells via 5 a reductase stimulates growth factor receptors on both epithelial and stromal cells

17
Q

irritative symptoms of BPH

A

urgency
frequency
nocturia
dysuria

18
Q

obstructive symptoms of BPH

A

hesitancy
weakening of stream
terminal dribbling
incomplete evacuation

19
Q

potential complications of BPH

A
urinary retention
-cystitis
-urolithiasis
bladder hypertrophy and hyperplasia
-thick wall
-trabeculation
-diverticulosis
vesicoureteric reflex
-hydroureter/ hydronephrosis
-pyelonephritis
renal dysfunction
-postrenal renal failure
-hypertension
20
Q

treatment of BPH

A

lifestyle modification
a1 adrenergic receptor antagonists
5a reductase inhibitors
TURP

21
Q

epidemiology of prostatic adenocarcinoma

A

most common form of cancer in men
19% of cancer, 8% of cancer death
incidence increases with age
less common in asians, more in africans

22
Q

pathogenesis of prostatic adenocarcinoma

A

multifactors: age, race, family history, hormone levels, and environmental influences
androgens
germline mutations in BRCA2

23
Q

tumor specific acquired somatic mutations in prostate cancer

A

gene fusion between ERG and TMPRSS2
MYC amplification
PTEN deletion
loss of TP53

24
Q

epigenetic alteration in prostate cancer

A

hypermethylation of GSTP1 gene

25
Q

clinical presentation of prostate cancer

A

localized is asymptomatic
LUTS
hematuria in advanced disease
back pain caused by vertebral metastases in rare patients (fatal outcome)

26
Q

metastatic prostate cancer

A

osteoblastic lesions; high density tumor nodules

fragile despite high density > lack normal remodeling

27
Q

detection of prostate cancer

A

DRE: low sens and spec
multiparametric MRI
serum PSA level: controversial

28
Q

describe PSA

A

secreted by prostatic epithelium
cutoff: 4 ng/mL
organ specific, not cancer-specific

29
Q

factors that can cause an elevated PSA

A
cancer
prostatitis
BPH
infarct
instrumentation of prostate
ejaculation
30
Q

limitations and potential harms of PSA screening

A

over diagnosis over treatment

false positive or false negative results

31
Q

PSA screening guidelines

A

don’t screen men <40
do not screen 40-54 at average risk
individualized screening for men < 55 at high risk
individualized screening for men 55-69
2 year or greater interval
do not screen men 70+ or those with less than 10-15 year life expectancy

32
Q

histo features of prostatic adenocarcinoma

A

small glands lined by a single layer of epithelium
loss of outer basal cell layer
large nuclei with one or more large nucleoli
perineural invasion

33
Q

what is perineural invasion

A

glands wrapped around a nerve

34
Q

people at higher risk for prostate cancer

A

african american

fam history of metastatic or lethal adenocarcinomas

35
Q

histological grading of prostate cancer

A

Gleason grade: 1-5

grading = predominant pattern + second most common pattern

36
Q

prostate tumor staging levels

A

pT2: organ confined
pT3: extraprostatic extension
pT3a: extraprostatic extension or microscopic invasion of bladder neck
pT3b: tumor invades seminal vesicles
pT4: tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter

37
Q

prognostic factors of prostate cancer

A

level of PSA
gleason grade
pathologic stage

38
Q

treatment options for prostate cancer

A

active surveillance: low grade only
radical prostatectomy: localized disease
external beam or interstitial radiation therapy: localized disease
hormonal manipulations: orchiectomy or agonists of LHRH for advanced metastatic disease